Workflow
爱朋医疗(300753) - 2023 Q1 - 季度财报
300753APON(300753)2023-04-23 16:00

Financial Performance - The company's revenue for Q1 2023 was ¥94,068,177.53, representing a 29.22% increase compared to ¥72,794,357.61 in the same period last year[5] - Net profit attributable to shareholders was ¥1,215,574.66, a significant turnaround from a loss of ¥10,987,817.03 in the previous year, marking an increase of 111.06%[5] - The net profit after deducting non-recurring gains and losses was ¥975,082.81, compared to a loss of ¥10,948,474.02 last year, reflecting an increase of 108.91%[5] - Operating profit for Q1 2023 was CNY 2,768,976.71, a significant recovery from a loss of CNY 12,312,975.32 in the same period last year[19] - Net profit for Q1 2023 was CNY 1,250,235.16, compared to a net loss of CNY 11,460,471.11 in Q1 2022, marking a turnaround in profitability[19] - The company reported a basic and diluted earnings per share of CNY 0.0096, recovering from a loss of CNY 0.0872 per share in the previous year[19] Cash Flow - Cash flow from operating activities showed a net outflow of ¥60,865,461.63, slightly worsening from a net outflow of ¥58,957,573.53 in the same period last year, a change of -3.24%[5] - Cash generated from operating activities was CNY 80,064,517.56, up from CNY 74,541,426.93 in Q1 2022, indicating improved cash flow[21] - The net cash flow from operating activities for Q1 2023 was -60,865,461.63 CNY, compared to -58,957,573.53 CNY in Q1 2022, indicating a slight increase in cash outflow[22] - Total cash inflow from operating activities was 87,834,681.51 CNY, while cash outflow totaled 148,700,143.14 CNY, resulting in a net cash flow deficit[22] - Cash flow from investing activities showed a net outflow of -142,921,162.72 CNY, significantly higher than -62,097,328.20 CNY in the same period last year[22] - Cash flow from financing activities resulted in a net outflow of -1,463,619.19 CNY, contrasting with a net inflow of 9,563,006.67 CNY in Q1 2022[22] - The ending balance of cash and cash equivalents was 43,501,364.85 CNY, down from 162,770,955.50 CNY at the end of Q1 2022[22] Assets and Liabilities - The company's total assets decreased by 5.07% to ¥826,125,197.49 from ¥870,213,234.55 at the end of the previous year[5] - Total liabilities decreased to CNY 138,512,800.30 from CNY 183,851,072.51, indicating a reduction in financial obligations[17] - The company’s equity attributable to shareholders increased to CNY 686,795,935.87 from CNY 685,580,361.21, showing slight growth in shareholder value[17] - The total current assets decreased from CNY 445,382,651.89 at the beginning of the year to CNY 400,705,725.07 by the end of the quarter, representing a decline of approximately 10%[15] - The total non-current assets slightly decreased from CNY 261,860,629.26 to CNY 261,498,926.17, a marginal decline of around 0.14%[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,800[9] - The company reported a reduction in restricted shares from 51,567,575 to 45,053,063, a decrease of approximately 13%[11] - Shareholder Zhang Zhihui reduced his holdings by 252,000 shares, accounting for 1.9992% of the total share capital[13] - Shareholder Guan Jifeng reported a reduction of 190,962 shares, representing 0.16% of the total share capital[13] Investments and R&D - The company’s investment activities resulted in a cash outflow of ¥142,921,162.72, which is a 130.16% increase compared to ¥62,097,328.20 in the same period last year[8] - The company has ongoing investments in long-term equity, with a slight decrease from CNY 50,125,753.65 to CNY 49,917,203.04[15] - Research and development expenses for Q1 2023 were CNY 9,687,121.04, slightly down from CNY 10,224,739.54 in Q1 2022, indicating a focus on cost management[18] Other Information - The company reported a significant increase in accounts receivable notes by 655.51%, reaching ¥11,895,464.09, primarily due to settlements from certain customers[8] - Cash and cash equivalents decreased significantly from CNY 249,251,608.39 to CNY 43,501,364.85, a drop of about 83%[15] - Accounts receivable increased from CNY 110,834,769.72 to CNY 122,070,035.20, indicating a growth of approximately 10%[15] - Inventory rose from CNY 61,039,583.17 to CNY 68,062,416.37, reflecting an increase of about 11%[15] - The company is focusing on expanding its market presence and developing new technologies, although specific figures were not disclosed in the report[13] - The first quarter report was not audited[23]